Clinical Study Begins for "Cell-Made Artificial Blood Vessels" Created by Bio 3D Printer

A clinical research study has been initiated in Japan, involving the transplantation of artificial blood vessels created using a bio 3D printer. This research is being conducted by the National Institutes for Quantum Science and Technology (QST) and the National Cerebral and Cardiovascular Center (NCVC), with support from the Japan Agency for Medical Research and Development (AMED).

The artificial blood vessels are constructed using a bio 3D printer, which precisely deposits cells and biomaterials to form a three-dimensional structure. This technology allows for the creation of customized vascular grafts that are designed to integrate seamlessly with the patient's own tissues. The goal is to overcome limitations associated with current treatments for vascular diseases, such as the scarcity of autologous blood vessels for grafting and the risks of infection or rejection with synthetic materials.

The clinical trial will focus on patients requiring vascular reconstruction, particularly those with conditions affecting peripheral arteries or veins. Researchers anticipate that these cell-made artificial blood vessels will promote better healing, reduce the incidence of thrombosis, and potentially lead to improved long-term outcomes compared to conventional methods. The study will meticulously monitor the performance and safety of the implanted grafts.